No Data
No Data
calliditas therapeutics (CALT.US) will release its financial report on November 11th.
$Calliditas Therapeutics (CALT.US)$ will release its financial report on November 11th, investors are welcome to pay attention. How was the previous performance? $Calliditas Therapeutics (CALT.US)$ revenue in 2024/Q2 was 0.55978 billion Swedish Krona, net income was -47.478 million Swedish Krona, and EPS was -1.76 Swedish Krona. Revenue in 2023/Q3 was 0.294592 billion Swedish Krona, net income was -0.168357 billion Swedish Krona, and EPS was -6.28 Swedish Krona. The above data
DJ Symbol for Calliditas Therapeutics AB (CALTX-SK) Now 3407.TO
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading
Delisting of Calliditas Therapeutics AB (Publ) From Nasdaq Stockholm
NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024
Notice of Extraordinary Meeting of Calliditas Therapeutics AB (Publ)